Related Experiment Video

Updated: Sep 23, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Systemic treatment in advanced melanoma: innovative perspectives

S Ugurel1, D Schadendorf

  • 1Klinische Kooperationseinheit Dermato-Onkologie, Deutsches Krebsforschungszentrum Heidelberg/Universitäts-Hautklinik Mannheim, Germany. s.ugurel@dkfz.de

Onkologie
|July 8, 2003
PubMed

Insights

Malignant melanoma with distant metastases has a poor prognosis. Innovative therapies, including chemosensitivity testing and advanced vaccination strategies, are being investigated to improve patient survival and overcome treatment resistance.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Malignant melanoma incidence is rising.
  • Early-stage melanoma offers a high cure rate after surgery.
  • Advanced melanoma with metastases has a poor prognosis despite various treatments.

Purpose of the Study:

  • To review innovative therapeutic strategies for malignant melanoma.
  • To highlight treatments currently in clinical trials.
  • To address challenges in melanoma therapy resistance.

Main Methods:

  • Review of clinical trials for advanced melanoma treatments.
  • Focus on pretherapeutic chemosensitivity testing.
  • Exploration of bcl-2 downregulation for chemosensitization.
  • Evaluation of dendritic cell vaccination and histamine immunomodulation.

Main Results:

  • Conventional cytotoxic treatments and cytokine combinations show limited efficacy in improving overall survival.
  • Research is actively elucidating mechanisms of melanoma therapy resistance.
  • New treatment concepts are emerging to overcome resistance.

Conclusions:

  • Standard therapies offer only temporary responses for metastatic melanoma.
  • Innovative strategies like targeted chemosensitization and advanced immunotherapies show promise.
  • Further clinical investigation is crucial for developing effective melanoma treatments.

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...